Affiliation: King Saud University, Riyadh 11461, Saudi Arabia, College of Medicine, Department of Anatomy, Stem Cell Unit

Dr. Amer Mahmood received his MSc from Copenhagen University in the field of autoimmune destruction of b-cells in Type 1 diabetic patients. He obtained his PhD in Medical Sciences in the field of human Embryonic Pluripotent Stem Cell research and bone biology from the University of Southern Denmark. Where he successfully differentiated human embryonic stem cells into mesoderm and further in bone, fat, and cartilage forming mesenchymal stem cells. He did his post-doctoral fellowship at the Biomedical Research Center, Department of The Molecular Endocrinology & Stem Cell Research Unit (KMEB, University of Southern Denmark), where he studied the expression of human DLK-1 a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice. Dr. Amer was Assistant Professor and Principal Investigator in Stem cell research at King Saud University in the Stem Cell Unit Department of Anatomy. In 2017, his recent research focus on the field of Mesenchymal Stem Cells and Regenerative Medicine, particularly in skeletal-bone disorders. Dr. Amer has also been working extensively in the field of small RNA including micro-RNA and siRNA in addition to a Nano-fibrous scaffold for bone-, blood vessel, and cartilage regeneration. Also, in one of his projects, his group is looking at the differentiation of iPSCs into different mesodermal lineages. Dr. Amer’s group has also initiated the first clinical trial with adult stem cells in Saudi Arabia.